Eun-Ju Lee

Eun-Ju Lee

Auto-generated profile, based on publicly available information

Eun-Ju Lee

Research Institute of T&R Biofab Co., Ltd, Seongnam, Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Polymers
Verified
Journal Article
Open access
PDF file
WJWoo Shik Jeong
Woo Shik Jeong
YKYoung Chul Kim
Young Chul Kim
JMJae-Cheong Min
Jae-Cheong Min
HPHo-Jin Park
Ho-Jin Park
ELEun-Ju Lee
Eun-Ju Lee
JCJong Woo Choi
Jong Woo Choi
(1) Background: In the present study, we evaluated the efficacy of a 3D-printed, patient-specific polycaprolactone/beta tricalcium phosphate (PCL/β-TCP) scaffold in the treatment of complex zygomatico-maxillary defects. (2) Methods: We evaluated eight patients who underwent immediate or delayed maxillary reconstruction with patient-specific PCL implants between December 2019 and June 2021. The efficacy of these techniques was assessed using the volume and density analysis of computed tomography data obtained before surgery and six months after surgery. (3) Results: Patients underwent maxillary reconstruction with the 3D-printed PCL/β-TCP scaffold based on various reconstructive techniques, including bone graft, fasciocutaneous free flaps, and fat graft. In the volume analysis, satisfactory volume conformity was achieved between the preoperative simulation and actual implant volume with a mean volume conformity of 79.71%, ranging from 70.89% to 86.31%. The ratio of de novo bone formation to total implant volume (bone volume fraction) was satisfactory with a mean bone fraction volume of 23.34%, ranging from 7.81% to 66.21%. Mean tissue density in the region of interest was 188.84 HU, ranging from 151.48 HU to 291.74 HU. (4) Conclusions: The combined use of the PCL/β-TCP scaffold with virtual surgical simulation and 3D printing techniques may replace traditional non-absorbable implants in the future owing to its accuracy and biocompatible properties.

1 January 2023 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
OJOh Young Joo
Oh Young Joo
TKTae Ho Kim
Tae Ho Kim
YKYoung Seok Kim
Young Seok Kim
TRTai Suk Roh
Tai Suk Roh
ELEun-Ju Lee
Eun-Ju Lee
IYIn Sik Yun
In Sik Yun
Joo OY, et al. Yonsei Med J. 2023 Apr;64(4):291-296. https://doi.org/10.3349/ymj.2022.0547

1 January 2024 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
MKMijung Kim
Mijung Kim
YKYun Jung Kim
Yun Jung Kim
YKYoung Seok Kim
Young Seok Kim
TRTai Suk Roh
Tai Suk Roh
ELEun-Ju Lee
Eun-Ju Lee
IYIn Sik Yun
In Sik Yun
Kim M, et al. Yonsei Med J. 2024 Jun;65:e31. https://doi.org/10.3349/ymj.2023.0444